Benzinga's Top Upgrades

Analysts at Macquarie upgraded

from Neutral to Outperform. New Oriental Education shares closed at $27.73 on Thursday. Baird upgraded

from Neutral to Outperform. Trimble Navigation shares closed at $18.74 on Thursday. Analysts at Raymond James upgraded

from Market Perform to Outperform. Abiomed shares closed at $70.40 on Thursday. Analysts at H.C. Wainwright upgraded

from Neutral to Buy. The price target for Vertex Pharmaceuticals has been raised from $85 to $155. Vertex Pharmaceuticals shares closed at $126.17 on Thursday. Deutsche Bank upgraded

from Hold to Buy. The price target for PPL has been raised from $34.50 to $36. PPL shares closed at $33.79 on Thursday. Wedbush upgraded

from Neutral to Outperform. The price target for ON Semiconductor has been raised from $12 to $14. ON Semiconductor shares closed at $10.28 on Thursday. Analysts at Canaccord Genuity upgraded

from Hold to Buy. The price target for B/E Aerospace has been raised from $50 to $60. B/E Aerospace shares closed at $47.56 on Thursday. Analysts at Morgan Stanley upgraded

from Underweight to Equal-weight. The price target for NVIDIA has been raised from $21 to $28. NVIDIA shares closed at $27.68 on Thursday. Baird upgraded

from Neutral to Outperform. CONE Midstream Partners shares closed at $8.92 on Thursday. Piper Jaffray upgraded

from Underweight to Neutral. The price target for Seattle Genetics has been raised from $30 to $44. Seattle Genetics shares closed at $42.14 on Thursday.